Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
VBI Vaccines
3204
VBI Vaccines
Technology
Biotechnology
VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets.
Suggest edits
Type
B2b
Founded
2001
Raised
$74.6M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Biogen
Xconomy
HubSpot
Money Mover
Formlabs
Akamai
General Catalyst
Companies in the same industry
Aprecia Pharmaceuticals
Biomoti
EO2 Concepts
Morphogen-IX
SeraCare Life Sciences
AtheroNova Inc.
Fusion Antibodies
InnoCyte
Medtrics Lab
to-BBB
Alexa global traffic share
Twitter followers
Overview
Funding
3
Acquisitions
1
Add info
Latest funding
Show all
$50,000,000
Post-IPO debt - 2020
K2 HealthVentures
$13,610,000
Post-IPO equity - 2016
Team Size
10+
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
Pulse 2.0
VBI Vaccines (VBIV) Stock: Why The Price Increased
Pulse 2.0
VBI Vaccines (VBIV) Stock: Why The Price Surged Today
Pulse 2.0
VBI Vaccines (VBIV) Raises $50 Million In Debt Financing
FinSMEs
VBI Vaccines Secures $50M Debt Financing
